LeukoSight's Grant

LeukoSight raised a round of funding on April 21, 2009. Investors include Maryland Technology Development Corporation.

LeukoSight Inc. is an early stage biotechnology company developing a line of therapeutics that can be used to treat autoimmune and inflammatory diseases.…

Articles about LeukoSight's Grant: